Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Encephalitis survivors experience hidden mental health struggles and there is an urgent need for improved support within the ...

Among those ever hospitalized for treatment of depression, the rate of death by ... About 60 percent of people who kill themselves have a mood disorder that s potentially treatable; younger ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.

The company said that the nasal spray is a ketamine-derived drug, first approved in 2019, to be used in combination with ...